Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent the intracoronary stenting and angiographic restenosis-test equivalence between 2 drug-eluting stents (ISAR-TEST) trial
Catheterization and Cardiovascular Interventions, 04/03/2012
King L – Overall there was no significant difference in clinical outcomes between polymer–free sirolimus–eluting stent (PF–SES) and paclitaxel–eluting stent (PES) to 5 years. Extended follow–up supports the durability of efficacy and safety of PF–SES.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.